TY - JOUR
T1 - Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines
AU - Alcolea, Verónica
AU - Plano, Daniel
AU - Karelia, Deepkamal N.
AU - Palop, Juan Antonio
AU - Amin, Shantu
AU - Sanmartín, Carmen
AU - Sharma, Arun
N1 - Publisher Copyright:
© 2016 Elsevier Masson SAS. All rights reserved.
PY - 2016/5/4
Y1 - 2016/5/4
N2 - A series of novel selenourea derivatives and corresponding thiourea analogs were synthesized and tested against a panel of six human cancer cell lines: melanoma (1205Lu), lung carcinoma (A549), prostatic carcinoma (DU145), colorectal carcinoma (HCT116), pancreatic epithelioid carcinoma (PANC-1) and pancreatic adenocarcinoma (BxPC3). In general, we found that the selenium-containing derivatives were more potent than their isosteric sulfur analogs. Four selenourea derivatives (1e, 1f, 1g and 1i) showed IC50 values below 10 μM in all of tested cell lines at 72 h. On the basis of its potent activity, compound 1g was selected for further biological evaluation in different colon cancer cell lines. Our results indicated that compound 1g induced apoptosis by caspase activation, along with inhibition of anti-apoptotic proteins.
AB - A series of novel selenourea derivatives and corresponding thiourea analogs were synthesized and tested against a panel of six human cancer cell lines: melanoma (1205Lu), lung carcinoma (A549), prostatic carcinoma (DU145), colorectal carcinoma (HCT116), pancreatic epithelioid carcinoma (PANC-1) and pancreatic adenocarcinoma (BxPC3). In general, we found that the selenium-containing derivatives were more potent than their isosteric sulfur analogs. Four selenourea derivatives (1e, 1f, 1g and 1i) showed IC50 values below 10 μM in all of tested cell lines at 72 h. On the basis of its potent activity, compound 1g was selected for further biological evaluation in different colon cancer cell lines. Our results indicated that compound 1g induced apoptosis by caspase activation, along with inhibition of anti-apoptotic proteins.
UR - http://www.scopus.com/inward/record.url?scp=84958969616&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958969616&partnerID=8YFLogxK
U2 - 10.1016/j.ejmech.2016.02.042
DO - 10.1016/j.ejmech.2016.02.042
M3 - Article
C2 - 26922233
AN - SCOPUS:84958969616
SN - 0223-5234
VL - 113
SP - 134
EP - 144
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
ER -